These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6767485)

  • 21. Mechanism of reduction of nitrofurantoin on liver microsomes.
    Leskovac V; Popović M
    Pharmacol Res Commun; 1980 Jan; 12(1):13-27. PubMed ID: 7384160
    [No Abstract]   [Full Text] [Related]  

  • 22. The role of NADH in uncoupled microsomal monoxygenations.
    Staudt H; Lichtenberger F; Ullrich V
    Eur J Biochem; 1974 Jul; 46(1):99-106. PubMed ID: 4153145
    [No Abstract]   [Full Text] [Related]  

  • 23. Reduced nicotinamide adenine dinucleotide-dependent reduction of tertiary amine N-oxide by liver microsomal cytochrome P-450.
    Sugiura M; Iwasaki K; Kato R
    Biochem Pharmacol; 1977 Mar; 26(6):489-95. PubMed ID: 192244
    [No Abstract]   [Full Text] [Related]  

  • 24. Studies on the mechanism of hepatic microsomal N-oxide formation. N-oxidation of NN-dimethylaniline by a reconstituted rabbit liver microsomal cytochrome P-448 enzyme system.
    Hlavica P; Hülsmann S
    Biochem J; 1979 Jul; 182(1):109-16. PubMed ID: 115464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulative mechanisms in NADH- and NADPH-supported N-oxidation of 4-chloroaniline catalyzed by cytochrome b5-enriched rabbit liver microsomal fractions.
    Golly I; Hlavica P
    Biochim Biophys Acta; 1987 Jun; 913(2):219-27. PubMed ID: 3109485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunochemical study on the route of electron transfer from NADH and NADPH to cytochrome P-450 of liver microsomes.
    Noshiro M; Harada N; Omura T
    J Biochem; 1980 Nov; 88(5):1521-35. PubMed ID: 7462192
    [No Abstract]   [Full Text] [Related]  

  • 27. Reduced diphosphopyridine nucleotide synergism of the reduced triphosphopyridine nucleotide-dependent mixed-function oxidase system of hepatic microsomes. II. Role of the type I drug-binding site of cytochrome P-450.
    Correia MA; Mannering GJ
    Mol Pharmacol; 1973 Jul; 9(4):470-85. PubMed ID: 4146890
    [No Abstract]   [Full Text] [Related]  

  • 28. N-Oxide reduction by hemoglobin, cytochrome C and ferrous ions.
    Powis G; DeGraw CL
    Res Commun Chem Pathol Pharmacol; 1980 Oct; 30(1):143-50. PubMed ID: 6254119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of flavin-containing monooxygenase in the N-oxidation of the pyrrolizidine alkaloid senecionine.
    Williams DE; Reed RL; Kedzierski B; Ziegler DM; Buhler DR
    Drug Metab Dispos; 1989; 17(4):380-6. PubMed ID: 2571476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The interaction of hepatic microsomal cytochrome P-450 with fluroxene (2,2,2-trifluoroethyl vinyl ether) in vitro.
    Ivanetich KM; Bradshaw JJ; Marsh JA; Kaminsky LS
    Biochem Pharmacol; 1976 Apr; 25(7):779-84. PubMed ID: 7271
    [No Abstract]   [Full Text] [Related]  

  • 31. Flavin-containing monooxygenase: a major detoxifying enzyme for the pyrrolizidine alkaloid senecionine in guinea pig tissues.
    Miranda CL; Chung W; Reed RE; Zhao X; Henderson MC; Wang JL; Williams DE; Buhler DR
    Biochem Biophys Res Commun; 1991 Jul; 178(2):546-52. PubMed ID: 1907134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Species differences in the hepatic microsomal enzyme metabolism of the pyrrolizidine alkaloids.
    Huan JY; Miranda CL; Buhler DR; Cheeke PR
    Toxicol Lett; 1998 Oct; 99(2):127-37. PubMed ID: 9817084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pyridine nucleotide involvement in rat hepatic microsomal drug metabolism--IV. Inhibition of aminopyrine and ethylmorphine-N-demethylases by 2.6-dihydroxy-acetophenone.
    Gourlay GK; Stock BH
    Biochem Pharmacol; 1979 Apr; 28(8):1421-5. PubMed ID: 36098
    [No Abstract]   [Full Text] [Related]  

  • 34. Growth hormone modulation of liver drug metabolic enzyme activity in the rat. I. Effect of the hormone on the content and rate of reduction of microsomal cytochrome P-450.
    Wilson JT
    Biochem Pharmacol; 1973 Jul; 22(14):1717-28. PubMed ID: 4146051
    [No Abstract]   [Full Text] [Related]  

  • 35. Chloroethanes : their metabolism by hepatic cytochrome P-450 in vitro.
    Ivanetich KM; Van den Honert LH
    Carcinogenesis; 1981; 2(8):697-702. PubMed ID: 7285278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nonenzymatic reduction of brucine N-oxide by the heme group of cytochrome P450.
    Takekawa K; Sugihara K; Kitamura S; Tatsumi K
    Biochem Mol Biol Int; 1997 Aug; 42(5):977-81. PubMed ID: 9285065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enflurane and methoxyflurane. Their interaction with hepatic cytochrome P-450 in vitro.
    Ivanetich KM; Lucas SA; Marsh JA
    Biochem Pharmacol; 1979 Mar; 28(6):785-92. PubMed ID: 36901
    [No Abstract]   [Full Text] [Related]  

  • 38. Metabolism in rat liver microsomes of the nitroxide spin probe tempol.
    Iannone A; Bini A; Swartz HM; Tomasi A; Vannini V
    Biochem Pharmacol; 1989 Aug; 38(16):2581-6. PubMed ID: 2764982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Self-catalysed, O2-independent inactivation of NADPH- or dithionite-reduced microsomal cytochrome P-450 by carbon tetrachloride.
    de Groot H; Haas W
    Biochem Pharmacol; 1981 Aug; 30(16):2343-7. PubMed ID: 7295345
    [No Abstract]   [Full Text] [Related]  

  • 40. Characterization of a metabolite-cytochrome P-450 complex derived from the aerobic metabolism of an insect juvenile hormone analog by rat microsomal fractions.
    Mayer RT; Prough RA
    Toxicol Appl Pharmacol; 1976 Nov; 38(2):439-54. PubMed ID: 11574
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.